- Home
- EXP vs CORT Comparison
EXP vs CORT Comparison
Compare EXP & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXP
- CORT
- Stock Information
- Founded
- EXP 1963
- CORT 1998
- Country
- EXP United States
- CORT United States
- Employees
- EXP N/A
- CORT N/A
- Industry
- EXP Building Materials
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- EXP Industrials
- CORT Health Care
- Exchange
- EXP Nasdaq
- CORT Nasdaq
- Market Cap
- EXP 6.4B
- CORT 7.5B
- IPO Year
- EXP 1994
- CORT N/A
- Fundamental
- Price
- EXP $223.38
- CORT $71.72
- Analyst Decision
- EXP Buy
- CORT Strong Buy
- Analyst Count
- EXP 9
- CORT 4
- Target Price
- EXP $262.78
- CORT $142.00
- AVG Volume (30 Days)
- EXP 437.3K
- CORT 1.6M
- Earning Date
- EXP 07-29-2025
- CORT 07-28-2025
- Dividend Yield
- EXP 0.45%
- CORT N/A
- EPS Growth
- EXP 1.18
- CORT 8.36
- EPS
- EXP 13.77
- CORT 1.14
- Revenue
- EXP $2,260,508,000.00
- CORT $685,446,000.00
- Revenue This Year
- EXP $2.63
- CORT $35.83
- Revenue Next Year
- EXP $5.43
- CORT $35.24
- P/E Ratio
- EXP $16.21
- CORT $62.92
- Revenue Growth
- EXP 0.05
- CORT 30.93
- 52 Week Low
- EXP $191.91
- CORT $30.77
- 52 Week High
- EXP $321.93
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- EXP 63.17
- CORT 50.50
- Support Level
- EXP $211.38
- CORT $66.49
- Resistance Level
- EXP $228.82
- CORT $72.49
- Average True Range (ATR)
- EXP 5.84
- CORT 2.85
- MACD
- EXP 3.01
- CORT -0.09
- Stochastic Oscillator
- EXP 83.53
- CORT 49.95
About EXP Eagle Materials Inc
Eagle Materials Inc produces and sells construction products and building materials. Construction products include cement, slag, concrete, and aggregates and building materials include cement and gypsum wallboard, and are sold to the construction and building industries. The firm organizes itself into two sectors: Heavy Materials, which includes the Cement and Concrete and Aggregates segments, and Light Materials, which includes the Gypsum Wallboard and Recycled Paperboard segments.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.